Tuberous sclerosis complex (TSC) is an autosomal dominant disorder caused by mutations in either the TSC1 or the TSC2 genes and characterized by the development of benign hamartomatous growths in multiple organ systems. We have inactivated Tsc1 in the mouse germ line by gene targeting in ES cells and confirmed that the mutant allele (Tsc1−) has a recessive embryonic lethal phenotype. We found that a significant number (∼27%) of heterozygous (Tsc1+/−) mice on the C57BL/6 background died before weaning (P=0.014) and show that these mice die in the post-natal period (P=0.033), normally at 1–2 days, from unknown causes. Forty-four percent (7/16) of Tsc1+/− mice on a C3H background developed macroscopically visible renal lesions as early as 3–6 ...
g.oxfordjournals.org/ D ow nloaded from 2 Tuberous Sclerosis Complex (TSC) is a neurodevelopmental d...
Tuberous sclerosis is an autosomal dominant genetic disorder characterised by the development of ben...
Clinical trials are underway for the treatment of tuberous sclerosis (TSC)-associated tumours using ...
Tuberous sclerosis complex (TSC) is an autosomal dominant disorder caused by mutations in either the...
Tuberous sclerosis complex (TSC) is an autosomal dominant disorder caused by mutation in either the ...
Summary: Tuberous sclerosis (TS) is a rare disorder exhibiting multi-systemic benign neoplasms. We h...
Tuberous Sclerosis Complex (TSC) is an autosomal dominant tumor suppressor gene syndrome in which pa...
Hamartomas are benign growths developed in tuberous sclerosis complex (TSC) patients in multiple org...
Tuberous sclerosis complex (TSC) is caused by mutations in either the TSC1 or TSC2 gene. Both genes...
Tuberous sclerosis (TSC) is an autosomal dominant disorder caused by germline mutations in either TS...
Tuberous sclerosis complex (TSC) is an autosomal dominant syndrome that is best characterised by neu...
Tuberous sclerosis complex (TSC) is an autosomal dominant syndrome that is best characterised by neu...
The autosomal dominant disease tuberous sclerosis (TSC) is caused by mutations in either TSC1 on chr...
Tuberous sclerosis complex (TSC), an autosomal dominant disease caused by mutations in either TSC1 o...
SUMMARY Tuberous sclerosis complex (TSC) is a dominantly inherited disease with high penetrance and ...
g.oxfordjournals.org/ D ow nloaded from 2 Tuberous Sclerosis Complex (TSC) is a neurodevelopmental d...
Tuberous sclerosis is an autosomal dominant genetic disorder characterised by the development of ben...
Clinical trials are underway for the treatment of tuberous sclerosis (TSC)-associated tumours using ...
Tuberous sclerosis complex (TSC) is an autosomal dominant disorder caused by mutations in either the...
Tuberous sclerosis complex (TSC) is an autosomal dominant disorder caused by mutation in either the ...
Summary: Tuberous sclerosis (TS) is a rare disorder exhibiting multi-systemic benign neoplasms. We h...
Tuberous Sclerosis Complex (TSC) is an autosomal dominant tumor suppressor gene syndrome in which pa...
Hamartomas are benign growths developed in tuberous sclerosis complex (TSC) patients in multiple org...
Tuberous sclerosis complex (TSC) is caused by mutations in either the TSC1 or TSC2 gene. Both genes...
Tuberous sclerosis (TSC) is an autosomal dominant disorder caused by germline mutations in either TS...
Tuberous sclerosis complex (TSC) is an autosomal dominant syndrome that is best characterised by neu...
Tuberous sclerosis complex (TSC) is an autosomal dominant syndrome that is best characterised by neu...
The autosomal dominant disease tuberous sclerosis (TSC) is caused by mutations in either TSC1 on chr...
Tuberous sclerosis complex (TSC), an autosomal dominant disease caused by mutations in either TSC1 o...
SUMMARY Tuberous sclerosis complex (TSC) is a dominantly inherited disease with high penetrance and ...
g.oxfordjournals.org/ D ow nloaded from 2 Tuberous Sclerosis Complex (TSC) is a neurodevelopmental d...
Tuberous sclerosis is an autosomal dominant genetic disorder characterised by the development of ben...
Clinical trials are underway for the treatment of tuberous sclerosis (TSC)-associated tumours using ...